Bispit Canada Ltd. Tablet
NDC Package 85631-002-01
Package Information
Bispit Canada Ltd. (bispit liver restoration tablets) tablets is a medication suitable for people at high risk ofchemical liver injury or those who have alreadydeveloped symptoms of injury, including: 1. This formulation utilizes a tablet delivery system. Marketed by Bispit Canada Ltd., this product is identified by NDC 85631-002.
Identification & Billing
Clinical Specifications
- BLACK PEPPER 60 mg/1.2g
- CHITOSAN OLIGOSACCHARIDE 12 mg/1.2g
- EPIMEDIUM PUBESCENS WHOLE 120 mg/1.2g
- GANODERMA LUCIDUM WHOLE 48 mg/1.2g
- LICORICE 24 mg/1.2g
- PUERARIA MONTANA VAR. LOBATA ROOT 60 mg/1.2g
- SCHISANDRA CHINENSIS WHOLE 240 mg/1.2g
- SILYBUM MARIANUM WHOLE 300 mg/1.2g
- TARAXACUM MONGOLICUM 180 mg/1.2g
- TAURINE 12 mg/1.2g
Regulatory & Marketing
Hierarchy Structure
- 85631 - Bispit Canada Ltd.
- 85631-002 - Bispit Canada Ltd.
- 85631-002-01 - 60 CARTON in 1 BOTTLE / 1.2 g in 1 CARTON
- 85631-002 - Bispit Canada Ltd.
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 85631-002-01 identifies a specific commercial package of 60 carton in 1 bottle / 1.2 g in 1 carton of Bispit Canada Ltd., a human over the counter drug labeled by Bispit Canada Ltd.. This tablet is formulated for oral use and contains black pepper; chitosan oligosaccharide; epimedium pubescens whole; ganoderma lucidum whole; licorice; pueraria montana var. lobata root; schisandra chinensis whole; silybum marianum whole; taraxacum mongolicum; taurine as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Bispit Canada Ltd. on June 05, 2025. The current certification is valid through December 31, 2026.
How is this Bispit Canada Ltd. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 85631000201. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.